OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Deciphering JAK/STAT signaling pathway: A multifaceted approach to tumorigenesis, progression and therapeutic interventions
Yihui Wang, Zhe Wang, Shuyu Li, et al.
International Immunopharmacology (2024) Vol. 131, pp. 111846-111846
Closed Access | Times Cited: 8
Yihui Wang, Zhe Wang, Shuyu Li, et al.
International Immunopharmacology (2024) Vol. 131, pp. 111846-111846
Closed Access | Times Cited: 8
Showing 8 citing articles:
Kinase Inhibitors and Kinase-Targeted Cancer Therapies: Recent Advances and Future Perspectives
Jiahao Li, Gong Chen, Haiting Zhou, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 10, pp. 5489-5489
Open Access | Times Cited: 10
Jiahao Li, Gong Chen, Haiting Zhou, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 10, pp. 5489-5489
Open Access | Times Cited: 10
Rewiring the T cell-suppressive cytokine landscape of the tumor microenvironment: a new frontier for precision anti-cancer therapy
Ludovica Lopresti, Vanessa Tatangelo, Cosima T. Baldari, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 1
Ludovica Lopresti, Vanessa Tatangelo, Cosima T. Baldari, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 1
Lestaurtinib’s antineoplastic activity converges on JAK/STAT signaling to inhibit advanced forms of therapy resistant ovarian cancer
Esther Rodman, Michael J. Emch, Xiaonan Hou, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Esther Rodman, Michael J. Emch, Xiaonan Hou, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Dual-responsive natural killer cell nano-engagers for cancer immunotherapy via inhibiting IL-6/JAK2/STAT3 pathway
Xiangrui Meng, Zhan Xue, Hang Xiao, et al.
Chemical Engineering Journal (2024) Vol. 499, pp. 156423-156423
Closed Access
Xiangrui Meng, Zhan Xue, Hang Xiao, et al.
Chemical Engineering Journal (2024) Vol. 499, pp. 156423-156423
Closed Access
Unraveling TRPV1’s Role in Cancer: Expression, Modulation, and Therapeutic Opportunities with Capsaicin
Subramanyam Reddy Chinreddy, Nicole Tendayi Mashozhera, Badraldeen Rashrash, et al.
Molecules (2024) Vol. 29, Iss. 19, pp. 4729-4729
Open Access
Subramanyam Reddy Chinreddy, Nicole Tendayi Mashozhera, Badraldeen Rashrash, et al.
Molecules (2024) Vol. 29, Iss. 19, pp. 4729-4729
Open Access
Interlinking pathways: a narrative review on the role of IL-6 in cancer and atherosclerosis
Riccardo Cau, Luca Saba
Cardiovascular Diagnosis and Therapy (2024) Vol. 14, Iss. 6, pp. 1186-1201
Open Access
Riccardo Cau, Luca Saba
Cardiovascular Diagnosis and Therapy (2024) Vol. 14, Iss. 6, pp. 1186-1201
Open Access
Targeting the JAK-STAT pathway in colorectal cancer: mechanisms, clinical implications, and therapeutic potential
Penghui Li, Di Huang
Frontiers in Cell and Developmental Biology (2024) Vol. 12
Open Access
Penghui Li, Di Huang
Frontiers in Cell and Developmental Biology (2024) Vol. 12
Open Access
Exploring the mechanism of Jianpi Lishi Jiedu Granules against postoperative recurrence of colorectal adenoma based on IL-6/JAK/STAT3 signaling pathway
Yuzhen Huang, Yulu Wang, Hao Wu, et al.
Cellular Signalling (2024), pp. 111535-111535
Closed Access
Yuzhen Huang, Yulu Wang, Hao Wu, et al.
Cellular Signalling (2024), pp. 111535-111535
Closed Access
